Docket: AR226-0002

All documents tagged with this AR226 identifier.

Page 1 of 1 — 2 documents
Title / Summary Year AR226 Docket Hash ID Pages
This letter from 3M's Medical Director, Larry R. Zobel, clarifies findings from a two-generation reproduction study on potassium perfluorooctanesulfonate (PFOS), stating that there were no significant effects on pup survival or growth at the 0.4 mg/kg/day dose, contrary to previous report language. 2000 AR226-0002 jNgGvaY0G1LkQZdpGq4oB76gp 6
This correspondence from 3M's Medical Director, Larry R. Zobel, clarifies findings from a two-generation reproduction study on potassium perfluorooctanesulfonate (PFOS), stating that there were no significant effects on pup survival or growth at the 0.4 mg/kg/day dose, contrary to earlier reports. 2000 AR226-0002 oe5g96njYYw5307mKrVBp3ZnX 6